|
Nrf2 activator | DN model | Results | Ref. |
|
Sulforaphane | T1DM mice; human renal tubular cells | Sulforaphane alleviates renal inflammation, oxidative stress, fibrosis, and dysfunction in DN mice via activation of Nrf2/ARE pathway (HO-1, SOD1, etc.); beneficial effects disappeared when Nrf2 siRNA was applied | [85] |
Sulforaphane | T1DM mice; human renal mesangial cells | Sulforaphane normalizes diabetes-induced kidney oxidative damage, fibrosis, and apoptosis, which is mediated by Nrf2/ARE pathway (NQO1, rGCS, and MRP2) activation; beneficial effects disappeared in Nrf2 knockout mice | [86] |
Sulforaphane | T2DM mice | Sulforaphane improves kidney oxidative damage, inflammation, and fibrosis in diabetic mice, accompanied by increasing kidney Nrf2 and its downstream gene metallothionein; beneficial effects disappeared in Nrf2 knockout mice | [89] |
Sulforaphane | T1DM rats | Sulforaphane ameliorates DN through GSK3β/Fyn/Nrf2 signaling pathway (prevents nuclear export of Nrf2) | [96] |
Resveratrol and rosuvastatin | T1DM mice | Resveratrol combined with rosuvastatin treatment normalizes the TGF-β1, FN, and NF-κB/p65 and restores Nrf2 in renal tissues of diabetic rats | [74] |
Resveratrol | T1DM rats; rat mesangial cells | Resveratrol reduces albuminuria and mesangial matrix expansion in DN rats and attenuates mesangial cell proliferation, which is associated with upregulation of Nrf2 and glutathione S-transferases Mu | [84] |
Resveratrol | T1DM rats | Resveratrol protects against DN by alleviating oxidative damage and inflammation through Nrf2/ARE pathway (SOD, CAT, etc.) | [87] |
Resveratrol | Rat primary glomerular mesangial cells | Resveratrol inhibits AGE-induced FN and TGF-β1 in glomerular mesangial cells through Sirt1/Nrf2 signaling pathway activation | [101] |
Polydatin (resveratrol analogue) | T1DM rats; rat glomerular mesangial cells | Polydatin inhibits AGE-induced FN and TGF-β1 in glomerular mesangial cells is associated with activation of Sirt1/Nrf2 pathway | [97] |
Curcumin | T2DM rats | Curcumin ameliorates albuminuria, kidney pathophysiologic changes, and urinary MDA, accompanied by increasing Nrf2, HO-1, and urinary SOD | [78] |
Curcumin | Rat kidney tubular epithelial cells | Curcumin protects renal tubular cells from high glucose-induced EMT through upregulating Nrf2 and HO-1; beneficial effects disappeared when Nrf2 siRNA was applied | [80] |
C66 (curcumin analogue) | T1DM mice | C66 protects against DN by upregulating Nrf2 via both increasing miR-200a and inhibiting miR-21; beneficial effects were partially abolished in Nrf2 knockout mice | [93] |
Zinc | Human renal tubular cells | Zn sensitizes Nrf2 by facilitating Akt-associated Fyn inhibition (prevents Nrf2 nuclear export) and thus alleviates kidney oxidative and inflammatory damage and fibrosis | [98] |
Zinc | Rat kidney tubular epithelial cells | Zinc ameliorates high glucose-mediated apoptosis in rat kidney tubular cells through Akt/ERK/Nrf2 signaling pathway activation (promotes Nrf2 accumulation in nuclear) | [99] |
MG132 | T1DM mice; human renal tubular cells | MG132 sensitizes Nrf2 by inhibiting proteasome activity and thus attenuates hyperglycemia-induced kidney oxidative and inflammatory damage, fibrosis, and eventual dysfunction; beneficial effects disappeared when Nrf2 siRNA was applied | [57] |
MG132 | T1DM rats | Low dose of MG132 prevents diabetes-induced kidney damage by Nrf2/ARE pathway activation | [106] |
Rutin | Human renal glomerular endothelial cells | Rutin significantly prevents hyperglycemia-induced glomerular endothelial barrier disruption by decreasing ROS through the activation of Nrf2 | [71] |
Berberine | T1DM mice; rat renal tubular epithelial cells | Berberine ameliorates high glucose-induced EMT and oxidative stress by Nrf2/ARE pathway (HO-1 and NQO1) activation and TGF-β/EMT pathway inhibition; beneficial effects disappeared when Nrf2 siRNA was applied | [72] |
Casein kinase 2 interacting protein-1 | Rat glomerular mesangial cells | Casein kinase 2 interacting protein-1 downregulates ICAM-1 and FN by Nrf2/ARE pathway (SOD1 and HO-1) activation | [73] |
Salvianolic acid A | T1DM mice | Salvianolic acid A protects DN via Nrf2/ARE pathway (HO-1, NQO1, and GPx-1) | [75] |
Sinomenine | Human renal glomerular endothelial cells | Sinomenine reduces ROS level and exerts renal protective effect by activating Nrf2 in high glucose-treated human renal glomerular endothelial cells | [76] |
Momordica charantia polysaccharides | T1DM rats | Momordica charantia polysaccharides attenuate type 1 DN in rats by upregulating Nrf2, CAT, GSH, and SOD | [77] |
Digitoflavone | T1DM mice | Digitoflavone minimizes pathological changes, decreases oxidative and inflammatory damage as well as fibrosis in DN mice, which is mediated by Nrf2 pathway (GCLC and HO-1) activation; beneficial effects disappeared in Nrf2 knockout mice | [78] |
Thrombomodulin domain 1 | T2DM mice | Thrombomodulin domain 1 improves DN by suppressing inflammation, activating the Nrf2 pathway, and inhibiting apoptosis in the mouse kidney | [82] |
Maxacalcitol | T2DM mice | Maxacalcitol alleviates DN by suppressing kidney oxidative and inflammatory damage as well as fibrosis, which is mediated by Nrf2 pathway (GCLC and HO-1) activation | [83] |
4-Phenylbutyric acid | T1DM rats | Treatment with 4-phenylbutyric acid attenuates oxidative damage in DN rats via Nrf2 facilitation | [88] |
Sodium butyrate | T1DM mice | Sodium butyrate protects against DN through Nrf2 upregulation, which is mediated by suppressing HDAC function; beneficial effects disappeared in Nrf2 knockout mice | [90] |
Connexin43 | Primary glomerular mesangial cells; type 2 diabetic mice | Connexin43 activates Nrf2/ARE pathway by means of inhibiting c-Src activity to hinder the nuclear export of Nrf2 and then downregulates FN, ICAM-1, and TGF-β1 expression and ultimately attenuates renal fibrosis in diabetic mice | [91] |
Minocycline | T1DM/T2DM mice; human/mouse podocytes | Minocycline stabilizes endogenous Nrf2 by reducing its ubiquitination and reduces markers of oxidative damage, thus alleviated DN; beneficial effects disappeared in Nrf2 knockout mice | [92] |
Mycophenolate mofetil | T1DM rats | Mycophenolate mofetil attenuates DN at least in part by upregulating Nrf2 pathway (increases the nuclear accumulation of Nrf2) | [94] |
Fenofibrate | T1DM mice | Fenofibrate attenuates DN via increasing FGF21 and activating Akt/GSK-3β/Fyn/Nrf2 pathway (prevents Nrf2 nuclear export) | [95] |
Hydrogen sulfide | T1DM rats; rat glomerular mesangial cells | Hydrogen sulfide alleviates DN by suppressing oxidative stress (promotes Nrf2 accumulation in nuclear), inflammation, and renin-angiotensin system activity, as well as by reducing mesangial cell proliferation | [100] |
Low-dose radiation | T1DM mice | Prevention of low-dose radiation against DN is associated with Akt phosphorylation and Nrf2 upregulation | [102] |
Hepatocyte growth factor | Rat mesangial cells | Hepatocyte growth factor ameliorates high glucose-induced oxidative damage in rat mesangial cells by upregulating 8-nitro-cGMP production, accompanied by nuclear accumulation of Nrf2 | [103] |
Telmisartan | T2DM mice | Telmisartan inhibits NAD(P)H oxidase and upregulates Nrf2 and SOD, leading to the attenuation of diabetes-induced renal damage | [104] |
tert-butylhydroquinone | T1DM mice | tert-butylhydroquinone reduces renal damage through nuclear accumulation of Nrf2 as well as its target genes in type 1 diabetic mice | [105] |
|